Tablets 20mg, 50mg, 70mg, 100mg, 150mg

Liquid 190mg/5mL (equivalent to 27.5mg iron per 5mL)

Only for use in neonates (SCBU)

Injection 50mg/mL

First line choice
For use in patients with asthma or eczema
For use when total dose infusion is needed

Injection 100mg/5mL

Second line after Ferinject

For intravenous use only

Do not use in patients with asthma or eczema

Injection 50mg/mL (2mL ampoule)

For use by renal unit only - preferred iron parenteral iron preparation for use by renal unit

1mg Tablets

  for treatment of non-dietary vitamin B12 deficiency when hydroxocobalamin injection is inappropriate or cannot be administered, and in dietary related deficiency only until B12 levels are replete, at which point patients are encouraged to self-care with 50-150mcg tablets daily purchased over the counter. 

  for maintenance therapy of dietary related insufficiency cyanocobalamin remains designated 'Do not prescribe' and patients are advised to self-care by purchase of 50mcg tablets over the counter. 

Concentrate for solution for infusion 300mg/3mL, 1,100mg/11mL, 300mg/30mL

Tertiary centres only

Off-label use for the treatment of autoimmune haemolytic anaemia in adults (AIHA)

Rituximab is recommended as an alternative treatment for adults with AIHA where patients are contraindicated to or fail to respond to standard active treatments (e.g corticosteroids).

Treatment requires initiation and continuation by specilist haematology services.

Tablets 90mg, 180mg, 360mg

For specialist prescribing by haematologists

Capsules 500 micrograms

Consultant haemtologist only

Tablets 20mg

  NICE TA853 for treating primary chronic immune thrombocytopenia - see link below

10mg powder and solvent for solution for injection

Tablets 25mg, 50mg

Consultant haematologist or specialist in hepatitis C therapy only

Film coated tablets, 100mg, 150mg

Film coated tablets 3mg

Injection 250 micrograms

Consultant haematologist only

Off-label use for the treatment of idiopathic thrombocytopenia in adults.

For use as an alternative 2nd line treatment in adults with ITP following failure of corticosteriod treatment or when corticosteroids and thrombopoietin receptor agonists are contraindicated

Treatment requires initiation and continuation and continuation by specialist haematology services

Oral powder sachets 8.4g, 16.8g

Oral powder 300g
Enema kit 30g

 In East Lancashire

Oral powder sachets 5g, 10g

Sachets

Injection 8.4% 10mL
Prefilled syringe injection 8.4% 10mL & 50mL
Intravenous infusion 1.26%, 1.4% 500mL Polyfusor^®
Intravenous infusion 8.4% 200mL Polyfusor^®

Chewable tablets 1.25g calcium 500mg (12.6mmol)

Effervescent tablets calcium 1000mg (25mmol)

Injection

Sachets 10mmol

 In East Lancashire

Tablets magnesium 4mmol
Liquid 1mmol/1mL - -Unlicensed

Intravenous infusion (phosphate 50mmol/500mL) 500mL

Tablets 1g

Tablets 475mg

Film coated tablets Calcium acetate, 435 mg equivalent to 110 mg calcium and Magnesium carbonate, heavy 235 mg equivalent to 60 mg magnesium

Tablets 250mg, 500mg, 750mg, 1000mg

Tablets 800mg

Sachets 2.4g

For treatment of head and neck cancer patients who have had surgery, radiotherapy and/or chemotherapy and are often left with severely dry mouths, restricted mouth opening, and reduced access for toothbrushing or professional dental care.

Should be prescribed on the advice of a secondary care specialist

  Prophylaxis of dental caries

Paravit-CF is a ‘Food for Special Medical Purposes’ for the dietary management of patients with cystic fibrosis and is reimbursable on FP10.
Paravit CF Capsules contain:
• Vitamin A 1.5 mg (=5,000IU)
• Vitamin D3 37.5 µg (=1,500IU)
• Vitamin E 100 µg (=150IU)
• Vitamin K 5 mg
Paravit CF capsules provide an alternative vitamin supplementation option for Cystic Fibrosis patients, which offers patients a decreased oral medication load whilst also being a cost-effective option.
Paravit CF liquid is only available as an option for patients with swallowing difficulties or young children.

Tablets 10mg, 50mg

  in East Lancashire

Not to be prescribed on TTO

Not for use in alcohol dependence

For refeeding and Post Bariatric Surgery only

Refer to local policies

Not for use in alcohol dependence - thiamine may be used

Tablets 50mg, 100mg, 200mg & 500mg
Effervescent tablets 1g with zinc

Only to be used for prophylaxis and treatment of scurvy

Capsules 250 nanograms, 1 microgram
Oral drops 2 micrograms/mL (1 drop = 100 nanograms)

For severe renal impairment

Prescribers initiating treatment should indicate monitoring requirements.

Capsules 250 nanograms

Follow local protocols

Injection 300,000 units

Consultant initiation only

Not to be used with plastic syringes

Suspension 500mg/5mL

Other preparations may be available but are unlicensed - contact pharmacy for advice

Tablets 10mg

water soluble preparation for patients with fat malabsorption

Dietary management of water-soluble vitamin deficiency in adults with renal failure on dialysis
For G.P prescribing

Tablets

On dieticians request only for patients with swallowing difficulties or enteral feeding tubes

 Post-surgery if gastric bypass

For use post bariatric surgery please consult link below

 Solution for infusion  2.8 x 10^11 Vector genomes/0.5mL

Tertiary Centre Only  HST26 Eladocagene exuparvovec for treating aromatic L-amino acid decarboxylase deficiency - See link below

Tertiary Centre

Solution for injection

100mg/ml, 40mg/ml

Powder for concentrate for solution for infusion 100mg - for treating Pompe disease - see link below

For treating Fabry disease

25mg solution for injection in pre-filled syringe

 for NICE TA868 Vutrisiran for treating hereditary transthyretin-related amyloidosis

Tablets 125mg

Injection 1g in 5mL

 Paediatric use only